We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pleuroparenchymal Fibroelastosis as a Late-Onset Pulmonary Toxicity after Treatment with Anticancer Chemotherapy for High-Risk Neuroblastoma.
- Authors
Yokoyama, Satoshi; Kanai, Risa; Fukao, Daisuke; Hamahata, Keigo
- Abstract
Pleuroparenchymal fibroelastosis (PPFE) is a rare, progressive, restrictive lung disease characterized by hypercarbic respiratory failure. In pediatrics, it has been described in patients with a history of malignancy who have received a bone marrow transplant, chemotherapy, or radiotherapy. It is characterized by pleural thickening, fibrosis, subpleural elastosis, and intraalveolar collagen deposits. Survival is poor, and the only therapy is lung transplantation. Here, we report a patient who developed PPFE as a late-onset pulmonary toxicity after treatment with anticancer chemotherapy for high-risk neuroblastoma (NB).
- Subjects
NEUROBLASTOMA; LUNG transplantation; CANCER chemotherapy; RESPIRATORY insufficiency; BONE marrow; LUNG diseases
- Publication
Case Reports in Pediatrics, 2024, Vol 2024, p1
- ISSN
2090-6803
- Publication type
Case Study
- DOI
10.1155/2024/4352032